DK165670C - Laegemidler indeholdende 9-desoxo-11-desoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)oxy)-(9s)-erythromycin samt fremgangsmaade til fremstilling af saadanne laegemidler - Google Patents

Laegemidler indeholdende 9-desoxo-11-desoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)oxy)-(9s)-erythromycin samt fremgangsmaade til fremstilling af saadanne laegemidler

Info

Publication number
DK165670C
DK165670C DK324786A DK324786A DK165670C DK 165670 C DK165670 C DK 165670C DK 324786 A DK324786 A DK 324786A DK 324786 A DK324786 A DK 324786A DK 165670 C DK165670 C DK 165670C
Authority
DK
Denmark
Prior art keywords
methoxyethoxy
imino
oxy
active substance
preparation
Prior art date
Application number
DK324786A
Other languages
Danish (da)
English (en)
Other versions
DK324786D0 (da
DK165670B (da
DK324786A (da
Inventor
Alain Etienne
Peter Gruber
Ulrich Busch
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK324786D0 publication Critical patent/DK324786D0/da
Publication of DK324786A publication Critical patent/DK324786A/da
Publication of DK165670B publication Critical patent/DK165670B/da
Application granted granted Critical
Publication of DK165670C publication Critical patent/DK165670C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK324786A 1985-07-10 1986-07-08 Laegemidler indeholdende 9-desoxo-11-desoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)oxy)-(9s)-erythromycin samt fremgangsmaade til fremstilling af saadanne laegemidler DK165670C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853524572 DE3524572A1 (de) 1985-07-10 1985-07-10 Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
DE3524572 1985-07-10

Publications (4)

Publication Number Publication Date
DK324786D0 DK324786D0 (da) 1986-07-08
DK324786A DK324786A (da) 1987-01-11
DK165670B DK165670B (da) 1993-01-04
DK165670C true DK165670C (da) 1993-06-07

Family

ID=6275375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK324786A DK165670C (da) 1985-07-10 1986-07-08 Laegemidler indeholdende 9-desoxo-11-desoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)oxy)-(9s)-erythromycin samt fremgangsmaade til fremstilling af saadanne laegemidler

Country Status (25)

Country Link
US (1) US4755385A (ja)
EP (1) EP0208971B1 (ja)
JP (1) JPH0688905B2 (ja)
KR (1) KR930010586B1 (ja)
AT (1) ATE63819T1 (ja)
AU (1) AU586262B2 (ja)
CA (1) CA1271138A (ja)
DD (1) DD248057A5 (ja)
DE (2) DE3524572A1 (ja)
DK (1) DK165670C (ja)
ES (1) ES2000269A6 (ja)
FI (1) FI85649C (ja)
GR (1) GR861762B (ja)
HK (1) HK79791A (ja)
HU (1) HU195730B (ja)
IE (1) IE58951B1 (ja)
IL (1) IL79375A (ja)
MX (1) MX9202785A (ja)
NL (1) NL970004I2 (ja)
NO (1) NO175351C (ja)
NZ (1) NZ216794A (ja)
PH (1) PH26147A (ja)
PT (1) PT82949B (ja)
SG (1) SG72191G (ja)
ZA (1) ZA865105B (ja)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
ZA922777B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical formulation containing dirithromycin
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
HU217629B (hu) * 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
DE69530973T2 (de) * 1994-02-16 2004-05-19 Abbott Laboratories, Abbott Park Verfahren zur herstellung feinteiliger pharmazeutischer formulierungen
CN1096862C (zh) * 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
US6045843A (en) * 1995-12-22 2000-04-04 Tamer International, Inc. Acid-reduced, whole bean coffee process
US5853787A (en) * 1995-12-22 1998-12-29 Tamer International Method for reducing coffee acidity
US6495180B1 (en) 1995-12-22 2002-12-17 Tamer International, Ltd. Acid reduced whole bean coffee and process
US6066342A (en) * 1995-12-22 2000-05-23 Tamer International, Ltd. Antacid composition
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US20020018754A1 (en) * 1999-03-15 2002-02-14 Paul Albert Sagel Shapes for tooth whitening strips
US6096328A (en) 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
US6582708B1 (en) 2000-06-28 2003-06-24 The Procter & Gamble Company Tooth whitening substance
PT1187601E (pt) 1999-06-07 2005-11-30 Altana Pharma Ag Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido
DE19925710C2 (de) * 1999-06-07 2002-10-10 Byk Gulden Lomberg Chem Fab Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer
MXPA02000262A (es) 1999-07-02 2005-08-16 Procter & Gamble Sistema de administracion para composiciones de cuidado oral que comprenden resinas de organosiloxano utilizando una tira de refuerzo removible.
EP1118321A1 (fr) * 2000-01-14 2001-07-25 Ucb, S.A. Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
CA2411055C (en) * 2000-06-28 2015-07-14 The Procter & Gamble Company Structures and compositions increasing the stability of peroxide actives
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20060127474A1 (en) * 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
US6949240B2 (en) * 2002-05-23 2005-09-27 The Procter & Gamble Company Tooth whitening products
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
WO2005009368A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005023184A2 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
AU2006226293B2 (en) 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
PL1916995T5 (pl) * 2005-07-29 2022-10-31 Stichting Groningen Centre For Drug Research Kontrolowany wartością ph impulsowy układ podawczy, sposoby przygotowania i zastosowanie
WO2007061829A2 (en) 2005-11-17 2007-05-31 Novartis Ag Pharmaceutical composition
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
WO2007126039A1 (ja) * 2006-04-28 2007-11-08 Shionogi & Co., Ltd. マクロライド系抗生物質の被覆製剤
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
BR112015008666B1 (pt) 2012-10-17 2020-04-07 Procter & Gamble produto extensível para tratamento dental e método de aplicação de um ativo para tratamento bucal
GB2533593A (en) * 2014-12-22 2016-06-29 Parkside Flexibles (Europe) Ltd Package

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081233A (en) * 1960-08-08 1963-03-12 Upjohn Co Enteric-coated pilules
US4000254A (en) * 1966-04-25 1976-12-28 Schmid Laboratories, Inc. Fungimycin compositions
US3784683A (en) * 1971-03-29 1974-01-08 Abbott Lab Tablet preparation
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US3891755A (en) * 1973-07-11 1975-06-24 Abbott Lab Dosage formulation for erythromycin cetyl sulfate
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4340582A (en) * 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法

Also Published As

Publication number Publication date
AU5987686A (en) 1987-01-15
NO862772D0 (no) 1986-07-09
EP0208971A3 (en) 1988-01-27
DE3679463D1 (de) 1991-07-04
PT82949A (de) 1986-08-01
DK324786D0 (da) 1986-07-08
CA1271138A (en) 1990-07-03
EP0208971A2 (de) 1987-01-21
IL79375A0 (en) 1986-10-31
DK165670B (da) 1993-01-04
HK79791A (en) 1991-10-18
IE58951B1 (en) 1993-12-01
SG72191G (en) 1991-11-22
ZA865105B (en) 1988-03-30
DK324786A (da) 1987-01-11
EP0208971B1 (de) 1991-05-29
NZ216794A (en) 1988-11-29
NO175351B (no) 1994-06-27
FI862898A0 (fi) 1986-07-10
NL970004I2 (nl) 1997-06-02
IL79375A (en) 1990-01-18
ES2000269A6 (es) 1988-02-01
AU586262B2 (en) 1989-07-06
FI85649C (fi) 1992-05-25
NO862772L (no) 1987-01-12
FI85649B (fi) 1992-02-14
JPS6212717A (ja) 1987-01-21
KR930010586B1 (ko) 1993-10-30
JPH0688905B2 (ja) 1994-11-09
NL970004I1 (nl) 1997-04-01
US4755385A (en) 1988-07-05
FI862898A (fi) 1987-01-11
NO175351C (no) 1994-10-05
KR870000920A (ko) 1987-03-10
HU195730B (en) 1988-07-28
ATE63819T1 (de) 1991-06-15
IE861842L (en) 1987-01-10
GR861762B (en) 1986-11-10
MX9202785A (es) 1992-06-30
DD248057A5 (de) 1987-07-29
HUT42945A (en) 1987-09-28
PH26147A (en) 1992-03-18
DE3524572A1 (de) 1987-01-15
PT82949B (pt) 1989-01-30

Similar Documents

Publication Publication Date Title
DK165670C (da) Laegemidler indeholdende 9-desoxo-11-desoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)oxy)-(9s)-erythromycin samt fremgangsmaade til fremstilling af saadanne laegemidler
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
DE3678661D1 (de) Arzneimittel mit langsamer wirkstofffreisetzung.
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
GR3032101T3 (en) Vehicles for oral administration of a specific pharmaceutically active acid labile substance.
HU906341D0 (en) Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
GEP19991686B (en) Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
HUT51620A (en) Process for producing multicyclic pyrimidine derivatives and pharmaceutical preparations containing these compounds as active substance
CS8804389A2 (en) Method of pharmaceutical preparation formulation with laminar structure for transdermal administration of active substance with null kinetic order
GB1445995A (en) Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
ES8702140A1 (es) Un procedimiento para la preparacion de una composicion de etoposido en forma de dosis unitaria para administracion oral
AU578766B2 (en) 1,3,4-Thiadiazole derivatives, processes for their preparation, and pharmaceutical preparations containing these compounds
IL83495A0 (en) Oxirane pseudooligosaccharides,a process for their preparation,and pharmaceutical preparations containing them
TH20304EX (th) สูตรปลดปล่อยที่ควบคุมซึ่งมีทรามาดอล
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
IT1238205B (it) Forma di somministrazione orale del fosfato di creatina e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
PUP Patent expired